Pharmoza.com - Medical Portal

New affordable hepatitis C combination shows 97% cure rate

The combination of sofosbuvir and the new NS5A inhibitor ravidasvir cured 97% of people with hepatitis C in a study carried out in Malaysia, and could provide a safe and effective cure for hepatitis C in low- and middle-income countries for $300 or less, researchers of the Drugs for Neglected Diseases Initiative reported on the opening day of the 2018 International Liver Congress in Paris.

Approximately 70 million people live with hepatitis C worldwide but access to curative treatment is restricted by price and by the lack of investments in health systems and viral hepatitis diagnosis and treatment.

Affordable pangenotypic treatment for hepatitis C would allow many lower- and middle-income countries to treat a wide range of people with hepatitis C, without the need for genotyping, reducing the cost of treating each patient.

Generic versions of some direct-acting antivirals are available but a combination that is suitable for treating any genotype is not available at low cost in countries where patent protection on sofosbuvir or daclatasvir exists.

Aids Cure - Bookshelf


A Cure Too Far, The struggle to end HIV/AIDS
336 pages
A Cure Too Far, The struggle to end HIV/AIDS

This story is informed by incredible personal accounts of individuals who played different roles in the war for survival, and of those who found the agony too much to bear, as the relentless scourge ripped apart thousands of years of ...

Encyclopedia of AIDS, A Social, Political, Cultural, and Scientific Record of the HIV Epidemic
650 pages
Encyclopedia of AIDS, A Social, Political, Cultural, and Scientific Record of the HIV Epidemic

From the outset of the epidemic, much attention has been focused on achieving a single, permanent solution to the AIDS crisis. Frustrated by a lack of progress toward either a vaccine or an effective anti-HIV therapy, by the late 1980s, activists in the United States often carried placards with photos of loved ones who had “died while waiting for the cure.” The strident, if minimalist, slogan “AIDS Cure Now” became a galvanizing cry for faster action. In the 1992 and 1996 U.S. presidential ...

AIDS, The Cause, the Curse, the Cure
184 pages
AIDS, The Cause, the Curse, the Cure


Understanding Aids Understanding Aids

AIDS can be tested and diagnosed, but an AIDS cure eludes us till date. We understand that AIDS is caused by a virus and so far no viral infection has been cured by antibiotics. There can be remission from viral disease, apparent recovery of health with no further symptoms, but once a virus family moves in, it is there to stay. The one and only alternative to cure is prevention- our only hope against AIDS. Researchers and Scientists are working day in and day out to find a magic bullet, ...

The Cure For Hiv And Aids
559 pages
The Cure For Hiv And Aids

In six weeks you are HIV Negative. What cause HIV/AIDS is really astonishing, but your body recovery will convince you. No conflict with any clinical treatment. Even near-terminal victims can recover.

Aids Cure - News


This RSS feed URL is deprecated


Motswana woman enhancing HIV/AIDS cure research
Motswana woman enhancing HIV/AIDS cure research Thirty years on, the cure for HIV/AIDS remains elusive, but researchers from various corners of the world are making enormous efforts and as the quest ensues, one Motswana woman, Dr Catherine Koofhethile, an immunologist, is in the thick of things and

Kerala sexologist claims to 'cure' homosexuality, LGBTQ community demands action
Kerala sexologist claims to 'cure' homosexuality, LGBTQ community demands action Nowadays, even cancer and AIDS can be cured. Then why can't we change homosexual behaviour? Because people are not trying to. But if a person wants to cure his homosexual behaviour, then who are we to tell him not to? It is very easy to correct this

Eight weeks of treatment with Epclusa cured almost all people with HCV receiving opioid substitution therapy
Eight weeks of treatment with Epclusa cured almost all people with HCV receiving opioid substitution therapy An eight-week course of sofosbuvir/velpatasvir (Epclusa) cured almost all people with hepatitis C genotype 3 without cirrhosis receiving treatment alongside opioid substitution therapy through community pharmacies or prisons in the Greater Glasgow area

San Diego Center for AIDS Research awarded $15 million grant
San Diego Center for AIDS Research awarded $15 million grant The federal institute's financial support of the research center extends back to 1994, at the height of the AIDS epidemic. “The grant renewal represents NIAID's continued and enduring investment in our mission to be a critical regional resource in HIV